Marrone Bio Innovations - MBII Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.80
+0 (0.00%)
Get New Marrone Bio Innovations Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MBII and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MBII

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Marrone Bio Innovations in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.80.

This chart shows the closing price for MBII for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Marrone Bio Innovations. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/18/2022Canaccord Genuity GroupDowngradeBuy ➝ Hold$2.00 ➝ $1.30High
11/11/2021Lake Street CapitalReiterated RatingBuy$2.50Low
9/22/2021Roth CapitalInitiated CoverageBuy$2.00Medium
9/16/2021Lake Street CapitalReiterated RatingBuy$2.50High
8/19/2021AegisLower TargetBuy$3.50 ➝ $2.50High
8/3/2021Lake Street CapitalReiterated RatingBuy$3.00High
3/24/2021HC WainwrightReiterated RatingBuy$2.50 ➝ $4.00High
2/11/2021AegisBoost TargetBuy$1.65 ➝ $3.50Low
8/14/2020AegisBoost TargetBuy$1.40 ➝ $1.65Medium
8/11/2020HC WainwrightReiterated RatingBuy$2.50High
5/14/2020AegisLower TargetBuy$2.00 ➝ $1.40Low
3/13/2020HC WainwrightReiterated RatingBuy$2.50Low
3/13/2020National SecuritiesReiterated RatingBuy$1.75Low
1/6/2020National SecuritiesReiterated RatingBuy$2.50N/A
8/12/2019HC WainwrightReiterated RatingBuy$2.50Low
8/9/2019National SecuritiesReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50High
7/30/2019National SecuritiesReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50Medium
7/24/2019AegisInitiated CoverageBuy$2.00Medium
5/10/2019National SecuritiesReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50High
(Data available from 4/26/2019 forward)

News Sentiment Rating

-0.59 (Sell)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/29/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/28/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
1/27/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/26/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Marrone Bio Innovations logo
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.
Read More

Today's Range

Now: $0.80
Low: $0.80
High: $0.80

50 Day Range

MA: $0.80
Low: $0.80
High: $0.80

52 Week Range

Now: $0.80
Low: $0.55
High: $1.55

Volume

38 shs

Average Volume

919,497 shs

Market Capitalization

$145.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Marrone Bio Innovations?

The following Wall Street analysts have issued reports on Marrone Bio Innovations in the last twelve months: StockNews.com.
View the latest analyst ratings for MBII.

What is the current price target for Marrone Bio Innovations?

0 Wall Street analysts have set twelve-month price targets for Marrone Bio Innovations in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Marrone Bio Innovations in the next year.
View the latest price targets for MBII.

What is the current consensus analyst rating for Marrone Bio Innovations?

Marrone Bio Innovations currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MBII.

What other companies compete with Marrone Bio Innovations?

How do I contact Marrone Bio Innovations' investor relations team?

Marrone Bio Innovations' physical mailing address is 1540 Drew Avenue, Davis CA, 95618. The basic materials company's listed phone number is (530) 750-2800 and its investor relations email address is [email protected]. The official website for Marrone Bio Innovations is www.marronebioinnovations.com. Learn More about contacing Marrone Bio Innovations investor relations.